**Earnings watch: Integrated Diagnostics Holdings (IDH) reported 1H16 results, posting net profit of EGP 126.5 mn and a 12% rise in revenues, according to its 1H2016 earnings release issued yesterday. IDH is the largest private sector medical diagnostics services provider in Egypt, established through the 2012 merger of Al Mokhtabar and Al Borg Laboratories. Speaking on the latest earnings statement, IDH Chairman Lord St John of Bletso said the company “continued to perform up to market expectations despite challenges regarding the availability of foreign exchange in Egypt that, compounded by rising inflation, have had a knock-on impact on consumer spending.” Chief Executive Officer Dr. Hend El Sherbini restated the company’s guidance for 15% revenue growth and EBITDA margins in the historical 43-45% range, noting the company has renegotiated key supplier contracts to mitigate possible cost inflation amid widespread expectation of devaluation.

Other earnings: GlaxoSmithKline’s Egypt division reported 1H2016 consolidated net loss of EGP 34.60 mn, down from a loss of EGP 103.96 mn recorded during the same period last year, according to a bourse statement.